Drugs / Pneumococcal conjugate vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00197821 | Jan 2004 → Dec 2008 | pneumococcal infection | Public Health England | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00622843 | Dec 2002 → Jul 2013 | HIV infectious disease, pneumococcal infection | Henry M. Jackson Foundation for the Advancement of Military Medicine | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 1 | NCT03109600 Comparator | Apr → Sep 2017 | — | PT Bio Farma | Completed | No outcome recorded |
| Phase 2 | NCT01437267 Comparator | Oct 2011 → Aug 2012 | typhoid fever | Novartis | Completed | No outcome recorded |
| Phase 2 | NCT01229176 Comparator | Mar 2011 → Jun 2012 | typhoid fever | Novartis | Completed | No outcome recorded |
| Phase 4 | NCT01402245 Comparator | Jan 2005 → Jun 2010 | streptococcal pneumonia | Helsinki University Central Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumococcal conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03109600 ↗ |
| Known as | 7vPnC | “We performed an open-label, randomized study that compared 7-valent pneumococcal conjugate vaccine (7vPnC) with PPV in 599 adults aged 50-80 years.” PMID 19814624 ↗ Nov 2009 |
| Modality | Vaccine | “7-valent pneumococcal conjugate vaccine (7vPnC)” PMID 19814624 ↗ Nov 2009 |
| Route | Intramuscular | “pneumococcal conjugate vaccine 0.5 ml i.m.” NCT01402245 ↗ |